Iatrogenic immunodeficiency-associated lymphoproliferative disease of the Hodgkin lymphoma-like variant in a patient treated with mycophenolate mofetil for autoimmune hepatitis.
Adams
Betsy
B
Lazarchick
John
J
Medina
Ana Maria
AM
Willner
Ira R
IR
Neville
Brad
B
Murphy
Edward
E
Stuart
Robert
R
Costa
Luciano J
LJ
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D001379:Azathioprine / Q000008:administration & dosage / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D020031:Epstein-Barr Virus Infections / Q000150:complications*; D005260:Female; D005882:Gingival Diseases / Q000188:drug therapy / Q000209:etiology / Q000821:virology; D019693:Hepatitis, Autoimmune / Q000188:drug therapy* / Q000276:immunology; D004854:Herpesvirus 4, Human / Q000502:physiology; D006689:Hodgkin Disease / Q000175:diagnosis; D006801:Humans; D007049:Iatrogenic Disease; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008232:Lymphoproliferative Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000821:virology; D008336:Mandibular Diseases / Q000188:drug therapy / Q000209:etiology* / Q000821:virology; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D019226:Oral Ulcer / Q000188:drug therapy / Q000209:etiology / Q000821:virology; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D012074:Remission Induction; D000069283:Rituximab; D014775:Virus Activation / Q000276:immunology
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000069283:Rituximab; D009173:Mycophenolic Acid; D001379:Azathioprine; D011241:Prednisone